Reneo Pharmaceuticals, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Reneo Pharmaceuticals, Inc.
AgomAb, CinCor and Confo Therapeutics secure Series A financing, while AlloVir closes a $121m Series B and more venture financing in April and May.
The start-up run by ex-Lumena leadership is testing REN001 for rare genetic mitochondrial diseases with two Phase Ib trials under way and plans to start a third later this year.
In Vivo briefly summarizes the technologies of these recently founded companies: Aeon Bioscience, Airmid, Centrose, Indigo Pharmaceuticals, Medella Therapeutics, and Xcovery.
Start-Up profiles these recently formed companies: Aeon Bioscience, Airmid, Indigo Pharmaceuticals, and Okairos AG.
- Specialty Pharmaceuticals